STI Hungary Acquires Complex 3H Thermal System Division

Logistics company STI Hungary has acquired a division of Hungary's Complex 3H that has developed a thermal system for maintaining temperatures of pharmaceutical shipments without an external power source for up to seven days, MTI reports.

In a statement, STI Hungary managing director Péter Csipes said the technology could be used for shipments of biotechnology substances, vaccines or clinical test materials requiring precise temperature control.

The technology is expected to account for 10-15% of STI Hungary's current pharma market activity. STI Hungary targets a 20-25% increase in turnover from pharma activities in the mid-term.

While several companies in the market offer specialized refrigerated packaging solutions, only a few global providers offer a comprehensive, end-to-end service that includes preconditioning, specialized packaging, multimodal transport, temperature monitoring, and compliance with Good Distribution Practice (GDP).

The company expects revenue from its pharmaceutical operations to grow by 20–25% in the medium term. The transaction is driven by significant market growth potential: the global pharmaceutical logistics market is currently valued at approximately USD 110 billion, while the annual growth rate of the cold-chain packaging market — which supports pharmaceutical cold chains — is projected to average 15.5% through 2033.